Document Detail

Methacholine delays pulmonary absorption of inhaled β(2)-agonists due to competition for organic cation/carnitine transporters.
MedLine Citation:
PMID:  22245488     Owner:  NLM     Status:  Publisher    
BACKGROUND: The aim of the present investigation was to compare the pulmonary absorption of the novel long-acting β(2)-agonist GW597901 with salbutamol and to determine the influence of an induced bronchoconstriction on the pharmacokinetics of the compounds using a human lung reperfusion model. METHODS: In an initial study with six lung perfusions the pharmacokinetic properties of the β(2)-agonists were determined. We then investigated the influence of an induced bronchoconstriction on the pulmonary absorption in six lung lobes for each drug. Therefore, methacholine (MCh) challenge agent was nebulised prior to administration of the β(2)-agonists. RESULTS: As expected, the extent of pulmonary absorption of salbutamol into the perfusate was more pronounced than for the more lipophilic GW597901. Although the observed differences were not statistically significant they were further supported by analysis of tissue concentrations. In contrast, we observed a statistically significant influence of the bronchoprovocation with MCh on the pulmonary absorption of both β(2)-agonists, but this effect was not limited to a successfully induced bronchoconstriction. A prominent decline of salbutamol distribution into perfusion fluid was also observed when the organic cation transporter substrate carnitine was nebulised prior to the bronchodilator. CONCLUSIONS: Nebulised methacholine had a significant influence on the pharmacokinetics of bronchodilators. Since we observed this effect independently of a successfully induced bronchoconstriction and also after nebulisation of carnitine we suggest a significant delay of pulmonary absorption of inhaled salbutamol and GW597901 due to competition for a cation/carnitine drug transporter, most likely OCTN2.
Mirjam Gnadt; Beatrice Trammer; Matthias Freiwald; Boris Kardziev; Martin K Bayliss; Chris D Edwards; Michael Schmidt; Godehard Friedel; Petra Högger
Related Documents :
3366738 - Quantification of pulmonary vascular occlusion in dogs by use of the diffusing capacity.
2441958 - Long-latency reflex activity in squirrel monkeys with occlusion of the middle cerebral ...
23112208 - Buntaro adachi (1865-1945): japanese master of human anatomic variation.
12185548 - Local intra-arterial thrombolysis in the carotid territory: does recanalization depend ...
14566238 - Acellularized porcine heart valve scaffolds for heart valve tissue engineering and the ...
7129408 - Pulmonary veno-occlusive disease in siblings: case reports and morphometric study.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-5
Journal Detail:
Title:  Pulmonary pharmacology & therapeutics     Volume:  -     ISSN:  1522-9629     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9715279     Medline TA:  Pulm Pharmacol Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier Ltd.
Universität Würzburg, Institut für Pharmazie und Lebensmittelchemie, Am Hubland, 97074 Würzburg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Salmeterol improves fluid clearance from alveolar-capillary membrane in COPD patients: a pilot study...
Next Document:  Heterophil/lymphocyte ratios predict the magnitude of humoral immune response to a novel antigen in ...